According to our findings, one of the main mechanisms of Roc in control of Imiq-induced psoriasis can be via its robust anti-inflammatory effect in the suppression of IL-17, IL-23, and TNF-α expression associated with skin inflammation. The gene discussed is IL17A; the disease is psoriasis.